AptaBio Therapeutics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	21,551	25,542	25,016	1,989
Short-Term Investments	1,020	1,020	19,000	15,026
Trading Asset Securities	-	4,954	8,869	-
Cash & Short-Term Investments	22,571	31,515	52,885	17,015
Cash Growth	-53.84%	-40.41%	210.81%	-
Accounts Receivable	1,242	893.71	-	-
Other Receivables	151.19	238.05	366.31	224.46
Receivables	1,588	1,435	2,659	3,047
Inventory	537.55	224.87	-	-
Prepaid Expenses	43.25	212.04	176.31	88.23
Other Current Assets	1,990	1,548	1,754	268.93
Total Current Assets	26,729	34,935	57,474	20,419
Property, Plant & Equipment	6,023	4,962	5,129	5,848
Long-Term Investments	29,647	30,986	23,779	27,885
Other Intangible Assets	34.26	39.35	61.09	37.83
Other Long-Term Assets	2,432	3,611	3,675	1,924
Total Assets	69,714	77,434	92,519	56,114
Accounts Payable	106.73	1.87	-	-
Accrued Expenses	608.03	609.79	337.19	455.54
Short-Term Debt	8,242	7,244	-	-
Current Portion of Leases	161.14	154.6	131.08	109.73
Current Income Taxes Payable	10.98	-	1.48	-
Other Current Liabilities	9,232	11,529	348.2	474.75
Total Current Liabilities	18,360	19,540	817.95	1,040
Long-Term Debt	-	-	13,569	-
Long-Term Leases	93.01	122.01	233.45	256.3
Other Long-Term Liabilities	83.48	71.4	13,524	54.58
Total Liabilities	22,213	23,237	31,156	3,744
Common Stock	13,441	13,441	11,149	11,149
Additional Paid-In Capital	149,733	149,733	129,712	109,025
Retained Earnings	-116,918	-110,112	-80,713	-68,473
Comprehensive Income & Other	1,245	1,135	696.37	668.63
Total Common Equity	47,501	54,197	60,845	52,370
Shareholders' Equity	47,501	54,197	61,363	52,370
Total Liabilities & Equity	69,714	77,434	92,519	56,114
Total Debt	8,496	7,521	13,934	366.03
Net Cash (Debt)	14,075	23,994	38,951	16,649
Net Cash Growth	-57.50%	-38.40%	133.95%	-
Net Cash Per Share	555.97	1019.11	1746.78	746.98
Filing Date Shares Outstanding	27.92	26.88	22.3	22.3
Total Common Shares Outstanding	27.92	26.88	23.34	22.3
Working Capital	8,369	15,395	56,656	19,379
Book Value Per Share	1701.40	2016.16	2607.28	2348.53
Tangible Book Value	45,972	54,158	60,784	52,332
Tangible Book Value Per Share	1646.61	2014.69	2604.66	2346.83
Land	2,115	1,787	1,787	1,922
Buildings	4,111	3,215	3,046	3,388
Machinery	1,329	1,268	1,196	1,101

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.